Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zai Lab Ltd ADR (NQ: ZLAB )

33.02 +0.53 (+1.65%)
Streaming Delayed Price Updated: 11:02 AM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 208,515
Open 32.45
Bid (Size) 33.01 (1)
Ask (Size) 33.10 (2)
Prev. Close 32.49
Today's Range 32.03 - 33.33
52wk Range 20.98 - 53.95
Shares Outstanding 956,637,360
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. SunCar Technology Group Inc. (NASDAQ: SDA) shares gained... 
Via Benzinga
Zai Lab Announces Participation in June Investor Conferences
From Zai Lab Limited
Via GlobeNewswire

Performance

YTD
+7.08%
+7.08%
1 Month
-5.07%
-5.07%
3 Month
-18.21%
-18.21%
6 Month
-14.35%
-14.35%
1 Year
+13.49%
+13.49%

More News

Read More
Why Shares of Alibaba, PDD, and Zai Lab Are Rising Today
Via The Motley Fool
Zai Lab Announces That Repotrectinib Granted Priority Review by China’s NMPA
From Zai Lab Limited
Via GlobeNewswire
Zai Lab: Q1 Earnings Insights
Via Benzinga
Earnings Preview For Zai Lab
Via Benzinga
FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections
Via Benzinga
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
From Zai Lab Limited
Via GlobeNewswire
Earnings Scheduled For May 9, 2023
Via Benzinga
Earnings Scheduled For March 1, 2023
Via Benzinga
Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in Oncology
From Zai Lab Limited
Via GlobeNewswire
Zai Lab Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
From Zai Lab Limited
Via GlobeNewswire
Zai Lab to Announce First Quarter 2023 Financial Results and Corporate Updates on May 9, 2023
From Zai Lab Limited
Via GlobeNewswire
Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting
From Zai Lab Limited
Via GlobeNewswire
1 Hot Growth Stock to Buy Hand Over Fist Before It Blasts Off
Via The Motley Fool
Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
From Zai Lab Limited
Via GlobeNewswire
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Via The Motley Fool
Silicon Valley Bank Collapse Might Have Limited Impact On Asia, But Confidence Seems Shaken
Via Benzinga
2 Stocks That Could Rebound and Rise 30% or More in 2023
Via The Motley Fool
Why Shares of MacroGenics Jumped Thursday
Via The Motley Fool
2 Growth Stocks With Incredible Potential in the Next 5 Years
Via The Motley Fool
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
Via Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
From Zai Lab Limited
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.